Medicines

Biosimilar literature review will inform policy

Thursday, 6 Oct 2016


As part of its biosimilar awareness initiative the Department of Health has published a review of all national and international clinical studies on biosimilars. According to the preface to the 55 page document, it will  be used to “inform policy development” and ensure that the core messages of the Initiative remain relevant in a changing environment.

To read the literature review in full click here. 

Already a member?

Login to keep reading.

OR
Email me a login link
logo

© 2022 the limbic